Volume Alert - CTSH 53.65 Cognizant Technology Solutions

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - CTSH 53.65 Cognizant Technology Solutions $CTSH Hit a high today of 54.24 Closing the day 11/10/14 at 53.65 +0.03 +0.06% With a day low of 53.31 and a total volume of 7,041,844.

CTSH Recent Posts: http://investorshangout.com/Cognizant-Technol...TSH-53834/

CTSH Cognizant Technology Solutions Recent Headline News

Cognizant Partners With CFA Institute to Enhance Financial Knowledge of Its Business Process Services Talent
Marketwired - Mon Nov 10, 7:00PM CST
CFA Institute today announced that Cognizant has become the first corporation in the global technology and business process services industry to adopt the Claritas Investment Certificate program, a comprehensive global program designed to give all professional disciplines in financial services outside of investment roles a clear understanding of the investment industry and their professional responsibilities within it.
CTSH: 53.65 (+0.03)

Third Quarter Results, Dividend Declarations, and New Services - Research Reports on LinkedIn, FireEye, CrownCastle, Cognizant and Level 3
PR Newswire - Mon Nov 10, 7:55AM CST
Today, Analysts Review released its research reports regarding LinkedIn Corporation (NYSE: LNKD), FireEye, Inc. (NASDAQ: FEYE), Crown Castle International Corp. (NYSE: CCI), Cognizant Technology Solutions Corporation (NASDAQ: CTSH) and Level 3 Communications, Inc. (NYSE: LVLT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7829-100free.
CCI: 79.91 (+0.11), LVLT: 46.29 (+0.44), FEYE: 32.39 (+1.77), LNKD: 229.25 (+6.21), CTSH: 53.65 (+0.03)

Do You Have The Patience To Be A Successful Value Investor?
Chuck Carnevale - at Seeking Alpha - Fri Nov 07, 2:24PM CST

LMT: 186.99 (+0.84), HPQ: 36.90 (+0.52), CTSH: 53.65 (+0.03), TUP: 64.52 (+0.98)

Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 245.73 (-0.18), COV: 93.64 (+1.56), CTSH: 53.65 (+0.03), TW: 114.67 (+0.01)

Cognizant Technology
at Investor's Business Daily - Wed Nov 05, 5:41PM CST
Cognizant Technology (CTSH) Q3 EPS fell 9.4% to 58 cents, missing estimates by a penny. Revenue jumped 11.9% to $2.581 bil, passing expectations for $2.567 bil. The IT services provider sees full-year EPS of at least $2.57, above projections for...
CTSH: 53.65 (+0.03)

India In Focus: Cognizant Breaks Out, Tata Bases
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Healthy third-quarter results sent Cognizant Technologies (CTSH) up more than 8% Wednesday and placed investor attention on a number of India-related stocks. Cognizant, which began as the Indian IT arm of Dunn & Bradstreet, is a world citizen....
F: 14.00 (-0.17), IBN: 57.99 (-0.02), HDB: 51.81 (-0.03), GM: 31.12 (-0.47), FCAU: 11.05 (+0.11), CTSH: 53.65 (+0.03), TTM: 46.54 (unch)

Cognizant Has Solid Quarter, Bullish on Health Care, IT Spending
at The Street - Wed Nov 05, 3:59PM CST
Cognizant Technology Solutions came in with solid third-quarter earnings and provided favorable guidance for the fourth quarter and fiscal year 2014.
IBM: 163.49 (+1.42), INFY: 67.76 (-0.24), CTSH: 53.65 (+0.03)

Cognizant Technology Solutions Rises 8.06% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:55PM CST
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $50.45 to a high of $52.60. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of $49.46 on volume of 10.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTSH: 53.65 (+0.03)

Cognizant Tech Solutions (CTSH) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Nov 05, 2:38PM CST
The following Cognizant Tech Solutions (CTSH) conference call took place on November 5, 2014, 08:00 AM ET. This is a transcript of that earnings call:
CTSH: 53.65 (+0.03)

Cognizant Technology Solutions' (CTSH) CEO Francisco D'Souza on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 12:18PM CST

CTSH: 53.65 (+0.03)

Cognizant CFO Karen McLaughlin Says Health Care, the Cloud Are Key to Growth
at The Street - Wed Nov 05, 12:10PM CST
Cognizant beat predictions on earnings, but now faces the challenge of becoming a major player in health care IT.
MCK: 201.28 (+1.96), WDAY: 95.16 (+0.60), CTSH: 53.65 (+0.03), HNT: 47.51 (+0.50), CERN: 63.42 (+0.41), CRM: 64.45 (+0.48)

Cognizant Technology Beats on Q3 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 12:00PM CST
Cognizant Technology Solutions Corp. (CTSH), reported third-quarter 2014 earnings of 66 cents per share, which beat the Zacks Consensus Estimate.
WIT: 12.46 (-0.09), INFY: 67.76 (-0.24), CTSH: 53.65 (+0.03), ACN: 84.16 (+0.68)

Cognizant (CTSH) Stock Soars on Increased Fourth Quarter Earnings Outlook
at The Street - Wed Nov 05, 11:14AM CST
Cognizant (CTSH) stock is rising after the company raised its fourth quarter earnings and revenue guidance, following its better than expected third quarter earnings this morning.
CTSH: 53.65 (+0.03)

Today's Unusual Social Activity Stock: Cognizant Technology Solutions (CTSH)
at The Street - Wed Nov 05, 8:59AM CST
Trade-Ideas LLC identified Cognizant Technology Solutions (CTSH) as an unusual social activity candidate
CTSH: 53.65 (+0.03)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:16AM CST

TTPH: 23.88 (-0.04), AWAY: 29.66 (+0.45), PHMD: 2.74 (-0.38), ROYT: 9.89 (+0.01), VG: 3.60 (+0.09), MEMP: 16.87 (-0.30), MACK: 8.70 (unch), ATVI: 20.92 (+0.27), NUS: 41.64 (+1.14), SSYS: 104.89 (+1.82), EOG: 98.50 (-1.05), CLNY: 24.35 (-0.19), CRTO: 36.45 (+0.26), IBIO: 1.23 (+0.07), NICE: 45.48 (+0.32), VPCO: 1.75 (-0.19), ZU: 28.83 (+0.33), EXEL: 1.79 (+0.05), ANV: 1.10 (+0.05), FEYE: 32.39 (+1.77), JIVE: 6.44 (-0.06), TRIP: 72.89 (-0.76), WLT: 3.16 (-0.03), YOD: 2.67 (-0.20), CHUY: 23.26 (+1.24), ANR: 2.64 (-0.27), NG: 2.69 (-0.18), AEZS: 0.62 (+0.05), ARIA: 6.29 (+0.21), CTSH: 53.65 (+0.03)

Cognizant +5.2% on Q3 beat, strong Q4 guidance
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 7:20AM CST

CTSH: 53.65 (+0.03)

Cognizant beats Street 3Q forecasts
Automated Insights - Wed Nov 05, 5:18AM CST
TEANECK, N.J. (AP) _ Cognizant Technology Solutions Corp. (CTSH) on Wednesday reported net income of $355.6 million in its third quarter.
CTSH: 53.65 (+0.03)

Cognizant Technology beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:01AM CST

CTSH: 53.65 (+0.03)

Cognizant Announces Third Quarter 2014 Results
PR Newswire - Wed Nov 05, 5:00AM CST
Cognizant Technology Solutions Corporation (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced its third quarter 2014 financial results.
CTSH: 53.65 (+0.03)

Cognizant Technology Solutions (CTSH) Stock Research Links

CTSH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk

Updated Category News Views 181

Class Action Lawsuit Against Alto Neuroscience, Inc. Alto Neuroscience, Inc. (NYSE: ANRO) is currently facing a class action lawsuit filed by a national shareholder rights litigation firm. This lawsuit revolves around allegations of securities fraud, claiming the company made misleading statements regarding the efficacy of its product ALTO-100 in treating major depressive...

Continue Reading
Hyatt and Playa Hotels Explore Strategic Partnership Options

Updated Category News Views 218

Hyatt Engages in Exclusive Discussions with Playa Hotels Hyatt Hotels (NYSE: H) is currently in exclusive negotiations regarding a potential takeover of Playa Hotels & Resorts (NASDAQ: PLYA) N.V. This engagement marks a significant move for both companies as they explore various strategic options for the $1.2 billion resort operator. The announcement has generated...

Continue Reading
LingoAce Celebrated as Top Innovator in Global Education Market

Updated Category News Views 111

LingoAce Celebrated as Top Innovator in Global Education Market Pioneering Tech-driven, Personalized Learning for over 580,000 Learners Worldwide LingoAce, a prominent global EdTech company, has received recognition as a 2025 Forbes China Influential Brand in Education. This honor was presented during the inaugural 2025 Forbes China Educational Industry Summit,...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 138

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
NV5 Global Backs Major Coastal Mapping Initiative in New Zealand

Updated Category News Views 197

NV5 Global Secures $4 Million Coastal Mapping Contract NV5 Global, Inc. (NASDAQ: NVEE), a significant player in the professional engineering field, has recently secured a noteworthy contract with Toit? Te Whenua Land Information New Zealand (LINZ) for a $4 million coastal mapping project. This contract is an important milestone in NV5's effort to expand its international...

Continue Reading